Ant Group Adopts Hybrid Chip Approach to Cut AI Costs

Ant Group, the fintech powerhouse affiliated with Alibaba, is strategically combining Chinese and U.S.-made semiconductors to enhance AI efficiency while reducing development costs, according to sources familiar with the matter.

This hybrid approach not only helps lower AI training expenses by 20%, but also reduces dependency on a single supplier like Nvidia—a growing trend in the AI industry. Ant’s "mixture of experts" (MoE) technique, which optimizes computational resources, allows the company to train models faster and more affordably by utilizing a diverse set of chips.

Balancing U.S. and Chinese Chips for AI Training

Earlier reports from Bloomberg revealed that Ant is using a combination of Nvidia, AMD, Alibaba, and Huawei chips for AI training. While Nvidia’s advanced GPUs have been crucial for AI development, U.S. trade restrictions have pushed Chinese tech firms to seek alternative semiconductor sources.

Ant’s recent shift towards AMD and domestic chips underscores China’s push for semiconductor independence in the wake of U.S. export controls that limit access to high-end AI chips.

Industry Insight:
The U.S. has imposed restrictions on China’s AI development by blocking access to top-tier semiconductors. Nvidia, however, is still permitted to sell lower-performance AI chips to Chinese firms, keeping a foothold in the market.

Ant’s AI Breakthroughs: More Than Just Cost Savings

Ant Group isn’t just cutting costs—it’s advancing AI-powered solutions across multiple industries. The company recently announced “major upgrades” to its AI healthcare solutions, already deployed in seven leading hospitals across major Chinese cities, including Beijing, Shanghai, Hangzhou, and Ningbo.

Ant’s Healthcare AI Model: A Game Changer?

Built on a powerful blend of AI models, including:

• DeepSeek R1 & V3
• Alibaba’s Qwen
• Ant’s proprietary BaiLing model

Ant’s healthcare AI can:
Answer complex medical inquiries
Enhance patient service efficiency
Support hospital operations

With China’s rapidly growing AI healthcare market, Ant is positioning itself as a key innovator in AI-driven medical assistance and patient care.

What This Means for the Future of AI in China

• China’s AI firms are diversifying chip supply chains to maintain growth amid U.S. trade restrictions.
• Hybrid chip strategies like Ant’s could set a precedent for other Chinese tech giants, reducing reliance on Western semiconductor suppliers.
• Cost-efficient AI training methods like MoE will make AI technology more scalable and accessible.

Ant Group’s adaptability in chip selection and AI advancements underscores China’s resilience in the AI race, despite mounting geopolitical pressures.

As global semiconductor competition heats up, Ant’s strategy could pave the way for a new AI development model—one that balances cost, performance, and supply chain flexibility in an increasingly divided tech landscape.

‍